149 related articles for article (PubMed ID: 38413976)
21. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease.
Li J; Zhao P; Li Y; Tian Y; Wang Y
Sci Rep; 2015 Oct; 5():15290. PubMed ID: 26469778
[TBL] [Abstract][Full Text] [Related]
22. Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS.
Yang L; Li J; Li Y; Tian Y; Li S; Jiang S; Wang Y; Song X
Evid Based Complement Alternat Med; 2015; 2015():956750. PubMed ID: 26170891
[TBL] [Abstract][Full Text] [Related]
23. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling.
Li J; Zhao P; Yang L; Li Y; Tian Y; Li S
Sci Rep; 2016 May; 6():25492. PubMed ID: 27146975
[TBL] [Abstract][Full Text] [Related]
24. AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD.
Ye R; Wang C; Sun P; Bai S; Zhao L
Front Pharmacol; 2021; 12():669403. PubMed ID: 34177583
[No Abstract] [Full Text] [Related]
25. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-β.
Schamberger AC; Mise N; Jia J; Genoyer E; Yildirim AÖ; Meiners S; Eickelberg O
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1040-52. PubMed ID: 24358952
[TBL] [Abstract][Full Text] [Related]
26. Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS.
Wu J; Cai B; Zhang A; Zhao P; Du Y; Liu X; Zhao D; Yang L; Liu X; Li J
Int J Anal Chem; 2022; 2022():1423801. PubMed ID: 36284795
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol attenuates cigarette smoke extract induced cellular senescence in human airway epithelial cells by regulating the miR-34a/SIRT1/NF-κB pathway.
Zeng XL; Yang XN; Liu XJ
Medicine (Baltimore); 2022 Nov; 101(46):e31944. PubMed ID: 36401446
[TBL] [Abstract][Full Text] [Related]
29. Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.
Zhang D; Liu B; Jie X; Deng J; Lu Z; Lu F; Liu X
Front Pharmacol; 2021; 12():761572. PubMed ID: 34867380
[TBL] [Abstract][Full Text] [Related]
30. Three Tiaobu Feishen therapies protect human alveolar epithelial cells against cigarette smoking and tumor necrosis factor--induced inflammation by nuclear factor-kappa B pathway.
Chen Y; Wu Y; Li J; Feng S; Hao L; Liu X; Zheng W; Dong H; Qin Y; Yin S; Zhao P; Chen Y; Wu Y; Li J; Feng S; Hao L; Liu X; Zheng W; Dong H; Qin Y; Yin S; Zhao P
J Tradit Chin Med; 2019 Feb; 39(1):45-49. PubMed ID: 32186022
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome-wide profiling discover: PM2.5 aggravates airway dysfunction through epithelial barrier damage regulated by Stanniocalcin 2 in an OVA-induced model.
Zhang L; He X; Xiong Y; Ran Q; Xiong A; Wang J; Wu D; Niu B; Li G
Ecotoxicol Environ Saf; 2021 Sep; 220():112408. PubMed ID: 34111662
[TBL] [Abstract][Full Text] [Related]
32. Methylprednisolone up-regulates annexin A1 (ANXA1) to inhibit the inflammation, apoptosis and oxidative stress of cigarette smoke extract (CSE)-induced bronchial epithelial cells, a chronic obstructive pulmonary disease in vitro model, through the formyl peptide receptor 2 (FPR2) receptors and the adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway.
Yu C; Zhang L
Bioengineered; 2022 Feb; 13(2):4028-4038. PubMed ID: 35129068
[TBL] [Abstract][Full Text] [Related]
33. Zinc deficiency as a codeterminant for airway epithelial barrier dysfunction in an ex vivo model of COPD.
Roscioli E; Jersmann HP; Lester S; Badiei A; Fon A; Zalewski P; Hodge S
Int J Chron Obstruct Pulmon Dis; 2017; 12():3503-3510. PubMed ID: 29255357
[TBL] [Abstract][Full Text] [Related]
34. Three Tiaobu Feishen formulae reduces cigarette smoke-induced inflammation in human airway epithelial cells.
Dong H; Liu X; Zheng W; Feng S; Li J; Qin Y; Wu Y; Chen Y; Yin S; Zhao P
J Tradit Chin Med; 2020 Jun; 40(3):386-392. PubMed ID: 32506851
[TBL] [Abstract][Full Text] [Related]
35. Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma signaling.
Li Y; Tian YG; Li JS; Dong YQ; Wang MH; Feng SX; Li LL; Mao J; Wang LL; Luo S
J Ethnopharmacol; 2016 Dec; 193():354-361. PubMed ID: 27562320
[TBL] [Abstract][Full Text] [Related]
36. Effective-components combination improves airway remodeling in COPD rats by suppressing M2 macrophage polarization via the inhibition of mTORC2 activity.
Liu L; Qin Y; Cai Z; Tian Y; Liu X; Li J; Zhao P
Phytomedicine; 2021 Nov; 92():153759. PubMed ID: 34600177
[TBL] [Abstract][Full Text] [Related]
37. SIRT1/FoxO3 axis alteration leads to aberrant immune responses in bronchial epithelial cells.
Di Vincenzo S; Heijink IH; Noordhoek JA; Cipollina C; Siena L; Bruno A; Ferraro M; Postma DS; Gjomarkaj M; Pace E
J Cell Mol Med; 2018 Apr; 22(4):2272-2282. PubMed ID: 29411515
[TBL] [Abstract][Full Text] [Related]
38. Tong Sai granule improves AECOPD via regulation of MAPK-SIRT1-NF-κB pathway and cellular senescence alleviation.
Tao L; Lu X; Fu Z; Tian Y; Liu X; Li J; Zhao P
J Ethnopharmacol; 2023 Oct; 314():116622. PubMed ID: 37210015
[TBL] [Abstract][Full Text] [Related]
39. Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules.
Liu B; Jie X; Deng J; Zhang S; Lu F; Liu X; Zhang D
Phytomedicine; 2023 Jun; 114():154767. PubMed ID: 37001297
[TBL] [Abstract][Full Text] [Related]
40. Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstructive Pulmonary Disease.
Mao J; Li Y; Feng S; Liu X; Tian Y; Bian Q; Li J; Hu Y; Zhang L; Ji H; Li S
Front Pharmacol; 2020; 11():587176. PubMed ID: 33390958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
